BioMed Realty Trust Inc. today announced the signing of a new lease agreement at the Pacific Research Center in Newark, Calif.

The value and terms of the agreement were not disclosed.

Revance Therapeutics Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative biopharmaceutical products for the aesthetic medicine and personal wellness categories, has agreed to occupy more than 90,000 square feet at BioMed’s multi-tenant research campus in Newark.

Revance will be relocating from the Mountain View area across the San Francisco Bay to join the life science cluster in the Newark/Fremont submarket, a primary component of the Bay Area’s life science market.

BioMed Realty Trust is a real estate investment trust focused on providing real estate to the life science industry. The company’s tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry.


***


What’s your opinion? Leave your comments below or send a
letter to the editor.


Show Comments Hide Comments

Comments

Sign up for Inman’s Morning Headlines
What you need to know to start your day with all the latest industry developments
Success!
Thank you for subscribing to Morning Headlines.
Back to top
Time is running out to secure your Connect Now tickets at the lowest price. Don't miss out on a chance to grow yourself and your business.Learn More×
Up-to-the-minute news and interviews in your inbox, ticket discounts for Inman events and more
1-Step CheckoutPay with a credit card
By continuing, you agree to Inman’s Terms of Use and Privacy Policy.

You will be charged . Your subscription will automatically renew for on . For more details on our payment terms and how to cancel, click here.

Interested in a group subscription?
Finish setting up your subscription